Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Scotts Miracle-Gro Company (NYSE: SMG) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and financial condition. As an Ohio‑incorporated issuer with common shares listed on the New York Stock Exchange, ScottsMiracle-Gro uses periodic reports and current reports to describe its branded consumer lawn and garden business, indoor and hydroponic growing operations and related financing arrangements.
On this page, you can review core filings such as the annual report on Form 10‑K and quarterly reports on Form 10‑Q, which include segment information for U.S. Consumer, Hawthorne and Other, along with discussions of risk factors, liquidity, capital resources and segment performance. These filings also elaborate on topics referenced in company news releases, such as gross margin trends, leverage, free cash flow and the role of credit facilities and receivables programs in the capital structure.
Current reports on Form 8‑K provide more targeted updates. Recent 8‑K filings describe a Seventh Amended and Restated Credit Agreement establishing senior secured loan facilities, amendments to a master receivables purchase agreement, results of operations for specific quarters and changes to the board of directors and equity award documentation. These filings outline key terms such as leverage and interest coverage covenants, security packages and the use of proceeds for working capital and general corporate purposes.
Definitive proxy statements on Schedule 14A offer detail on corporate governance and executive compensation. ScottsMiracle-Gro’s proxy materials cover board composition, committee responsibilities, director independence, say‑on‑pay proposals, long‑term incentive plan terms, stock ownership guidelines and severance and change‑in‑control arrangements.
This filings page combines real‑time access to new EDGAR submissions with AI‑generated summaries that explain the structure and implications of each document. Users can quickly identify items such as 10‑K and 10‑Q reports, 8‑K current reports, proxy statements and exhibits related to credit agreements or incentive plans, and use the summaries to focus on the sections most relevant to their analysis of SMG.
Scotts Miracle-Gro president and COO Nathan Eric Baxter reported an administrative change in his holdings of the company’s common shares. The Form 4 lists an “other transaction” involving 90.025 common shares at $55.54 per share, after which his directly held stake is shown as 66,722.4238 common shares.
The filing also updates indirect ownership information. It notes 36,993 common shares held through Hagedorn Partnership, L.P., a Delaware limited partnership where Baxter is a general partner. Under securities rules, he may be deemed a beneficial owner of a proportionate interest in those partnership-held shares.
Kingdon Mark D reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Mark D. Kingdon reported an award of 105 Dividend Equivalent Rights on common shares. These rights accrued on DSU or RSU grants at a price of $0.0000 per right, bringing his directly held Dividend Equivalent Rights to 552 following the transaction.
Each Dividend Equivalent Right is the economic equivalent of one common share and becomes exercisable proportionately with the related DSUs or RSUs.
Scotts Miracle-Gro Co director and major shareholder Katherine Littlefield Hagedorn reported an award of derivative securities tied to the company’s common stock. On the reported date, she acquired 33 dividend equivalent rights at a price of $0.00 per right, bringing her holdings of these rights to 33.
According to the disclosure, these dividend equivalent rights accrue on deferred or restricted stock unit grants and become exercisable in step with the underlying DSUs or RSUs. Each right is described as being economically equivalent to one common share of Scotts Miracle-Gro.
Scotts Miracle-Gro director Roberto Candelino reported an equity-related award. On March 6, 2026, he acquired 68 dividend equivalent rights at a price of $0.0000 per right, bringing his holdings in these instruments to 218 rights.
The footnote explains that these dividend equivalent rights accrue on DSU or RSU grants and become exercisable in step with the underlying DSUs or RSUs. Each right is described as the economic equivalent of one common share of Scotts Miracle-Gro, aligning the director’s compensation with shareholder outcomes.
Scotts Miracle-Gro executive Christopher Hagedorn reported a small change in his common share holdings. On February 27, 2026, a Form 4 lists an “other” type transaction involving 3.907 common shares at $55.54 per share. Following this adjustment, his directly owned stake stands at 57,531.3734 common shares.
SCOTTS MIRACLE-GRO CO Chairman & CEO James Hagedorn reported new equity-related activity. On March 6, 2026 he acquired 2,396.642 phantom stock units at $0 per unit, increasing his phantom stock balance to 237,393.148 units.
Each phantom stock unit represents the right to receive one common share of Scotts Miracle-Gro or its cash value and is payable in cash after his employment ends. He also reported indirect holdings of 31,533.640 common shares through a 401(k) plan and a proportionate interest in 997,910 common shares held by Hagedorn Partnership, L.P. A separate J-code transaction on February 27, 2026 involved 36.010 directly held common shares at $55.54 per share, leaving him with 87,471.9828 directly held common shares.
Scotts Miracle-Gro director Adam Hanft reported an equity-based compensation award. On March 6, 2026, he acquired 105 Dividend Equivalent Rights at a price of $0.00 per right as a grant or award. Following this transaction, he holds 552 Dividend Equivalent Rights directly. According to the disclosure, these rights accrue on DSU or RSU grants and become exercisable proportionately with those units, and each right is the economic equivalent of one common share of Scotts Miracle-Gro.
Johnson Stephen L reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Stephen L. Johnson received a grant of 138 Dividend Equivalent Rights on March 6, 2026. These rights were awarded at a price of $0.00 per right as a form of derivative-based compensation.
The dividend equivalent rights accrue on DSU or RSU grants and become exercisable proportionately with the DSUs or RSUs they relate to. Each right is the economic equivalent of one common share of Scotts Miracle-Gro. Following this award, Johnson directly holds a total of 750 Dividend Equivalent Rights.
Sandoval Brian E reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Brian E. Sandoval received an equity-related award. On the reported date, he was granted 151 dividend equivalent rights tied to existing deferred or restricted stock unit grants, at a stated price of $0 per right. Following this award, he holds 787 dividend equivalent rights, each economically equivalent to one common share.
Scheiwer Mark J reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO executive Mark J. Scheiwer, EVP, CFO & CAO, reported receiving a grant of 10.748 units of phantom stock on February 26, 2026. The award is recorded at a reference price of $69.78 per unit and is classified as a derivative security.
Each phantom stock unit represents the right to receive one common share of the company or the cash value of that share. The phantom stock is payable in cash after Scheiwer’s employment with the company ends, and he may move these units into an alternative investment at any time. Following this grant, he holds a total of 1,218.321 phantom stock units directly.